This in silico evaluation provides strong evidence supporting the potential clinical utility of the Accu-Chek SmartGuide Predict app for improving glycemic management in adults with T1D.
HERRERO et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: